CRIS Current Research Information System

COLECCHIA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.748
EU - Europa 4.403
AS - Asia 2.306
AF - Africa 281
SA - Sud America 12
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.760
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.732
GB - Regno Unito 1.414
CN - Cina 804
IT - Italia 638
VN - Vietnam 597
SE - Svezia 580
DE - Germania 561
SG - Singapore 529
UA - Ucraina 255
IN - India 249
RU - Federazione Russa 193
IE - Irlanda 192
FR - Francia 191
EE - Estonia 115
ZA - Sudafrica 113
CH - Svizzera 101
TG - Togo 65
JO - Giordania 53
CI - Costa d'Avorio 42
NG - Nigeria 39
BG - Bulgaria 34
FI - Finlandia 32
GR - Grecia 23
BE - Belgio 21
SC - Seychelles 21
JP - Giappone 16
IR - Iran 15
CA - Canada 14
PL - Polonia 11
NL - Olanda 10
LB - Libano 8
HK - Hong Kong 6
HR - Croazia 6
AU - Australia 5
CZ - Repubblica Ceca 5
AT - Austria 4
CL - Cile 4
ES - Italia 4
KR - Corea 4
TR - Turchia 4
BR - Brasile 3
DK - Danimarca 3
EC - Ecuador 3
IL - Israele 3
SA - Arabia Saudita 3
BD - Bangladesh 2
EU - Europa 2
MD - Moldavia 2
MM - Myanmar 2
MX - Messico 2
NZ - Nuova Zelanda 2
RO - Romania 2
TW - Taiwan 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
EG - Egitto 1
ID - Indonesia 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MK - Macedonia 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SI - Slovenia 1
Totale 13.760
Salva come PNG Salva come JPEG
Città #
Southend 1.308
Fairfield 941
Chandler 606
Ashburn 516
Singapore 474
Woodbridge 397
Houston 370
Wilmington 367
Seattle 365
Santa Clara 333
Dong Ket 317
Cambridge 290
Ann Arbor 276
Princeton 266
Dublin 192
Boardman 161
Jacksonville 152
Nanjing 131
Westminster 127
Padova 119
Bologna 113
Bern 86
Berlin 66
Lomé 65
New York 64
Saint Petersburg 62
San Diego 57
Medford 55
Amman 53
Shenyang 53
Dearborn 51
Beijing 49
Frankfurt am Main 49
Jinan 47
Abidjan 42
Abeokuta 39
Hebei 37
Milan 36
Sofia 33
Helsinki 32
Nanchang 32
Turin 32
Bremen 30
Changsha 29
Tianjin 29
Jiaxing 26
Mülheim 25
Redwood City 22
Guangzhou 21
Brussels 20
Florence 20
Mahé 20
Shanghai 19
Norwalk 18
Des Moines 17
Kuban 17
Ningbo 17
Falls Church 16
Hangzhou 16
Los Angeles 16
Mountain View 16
Tokyo 15
Haikou 13
Pune 12
Rome 12
Taizhou 12
Zhengzhou 12
Lanzhou 11
Taiyuan 11
Fuzhou 10
Leawood 10
Monmouth Junction 10
Torino 10
Verona 10
Kunming 9
Olalla 9
Shenzhen 9
Xi'an 9
Fort Worth 8
Groningen 8
Phoenix 8
Trieste 8
Wuhan 8
Andover 7
Falkenstein 7
Ferrara 7
Moscow 7
Paris 7
Toronto 7
Washington 7
Hanover 6
Hefei 6
Qingdao 6
Redmond 6
Zanjan 6
Augusta 5
Castelnuovo Rangone 5
London 5
Muizenberg 5
Orange 5
Totale 9.583
Salva come PNG Salva come JPEG
Nome #
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 219
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 216
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 211
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 202
Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. 184
null 179
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 175
Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. 172
Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach 168
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 162
Correlazione materno-fetale degli acidi biliari in corso di colestasi gravidica 162
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. 160
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 159
Benign hepatic nodular lesions after treatment for childhood cancer 156
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 151
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 146
Are noninvasive methods clinically useful in advanced, decompensated liver cirrhosis when "les Jeux Sont Faits"? 142
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 142
Body weight,lifestyle,dietary habits and gastroesophageal reflux disease 142
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 139
Biliary symptoms, gallbladder motility, and cholecystectomy 135
CMV infection and biliary tract complications are related with a poor outcome of liver transplantation for HCV-related cirrhosis 134
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 133
Autoimmune liver diseases in a paediatric population with coeliac disease. A 10-year single-centre experience 131
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 131
Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor? 129
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 129
Gut Microbiota and Celiac Disease 127
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 124
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 124
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 124
Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT 121
Management of hepatic encephalopathy: focus on antibiotic therapy 121
Calcolosi della colecisti complicata 119
Coeliac disease and autoimmune hepatitis: Gluten-free diet can influence liver disease outcome. 119
Focal nodular hyperplasia of the liver in children after hematopoietic stem cell transplantation. 119
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 119
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 117
Value of Transient Elastography Measured With Fibroscan in Predicting the Outcome of Hepatic Resection for Hepatocellular Carcinoma. 117
null 117
Breath tests with stable isotopes: have they a role in liver transplantation? 116
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant: Results of an open, uncontrolled multicenter study 116
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 115
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study 115
Non-invasive diagnostic approach to non-alcoholic fatty liver disease: Current evidence and future perspectives 114
Ductal stones recurrence after extracorporeal shock wave lithotripsy for difficult common bile duct stones: Predictive factors 114
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 114
Bacteria flora,gas and antibiotics 114
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 111
Pharmacological modulation of MRP2 in primary biliary cirrhosis 110
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation variant. Result of an open, uncontrolled , multicenter trial. 109
Prognostic factors for hepatocellular carcinoma recurrence 108
Gut microbiota and its pathophysiology in disease paradigms. 108
Efficacy of ursodeoxycholic acid administration on clinical manifestations of gallstones and gastrointestinal motility 107
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon 105
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation. 105
Gut microbiota and metabolic syndrome. 104
null 104
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 103
MALDI-TOF MS protein profiling using selective extraction with derivatized cellulose and chemometric analysis: from hepatitis C to hepatocellular carcinoma 102
A new point-of-care portable immunosensor for non-invasive assessment of oro-ileal transit time by oral fluid tauroursodeoxycholate measurement after its oral load. 102
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 102
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project). 102
Persistent Fever and Abdominal Pain in a Young Woman With Budd-Chiari Syndrome 101
Superior efficacy of twice a week administration of peginterferon alpha-2b plus ribavirin in obtaining SVR in HCV genotype 1 100
Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations 100
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference 100
Safety of interferon beta treatment for chronic HCV hepatitis. 99
Review article:the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods. 99
Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease - authors' reply. 99
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 99
Ecosistema intestinale: aspetti fisiopatologici e terapeutici 98
The role of Spleen Stiffness measurement as predictor of HCC recurrence after curative resection in cirrhotic patients 98
The Onset of de novo Hepatocellular Carcinoma after Liver Transplantation can be both of Donor and Recipient origin. A Case Report 98
Mesalazine and rifaximin in symptomatic uncomplicated diverticular disease 97
H 2breath testing for other gas-related syndromes 97
Transient Elastography (FibroScan) Is Not Correlated with Liver Fibrosis but with Cholestasis in Patients with Long-Term Home Parenteral Nutrition 97
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 97
Effects of UDCA on the foetus-maternal circulation of bilirubin in cholestasis of pregnancy 96
Calcolosi della colecisti 96
Development and application of a simple and powerful tool for nutrition and lifestyle education for the Italian general population by general practitioners and family paediatricians 95
null 95
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 95
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study 94
Risk factors for gallstone formation during weight loss 94
Dysbiosis in Celiac disease patients with persistent symptoms on gluten-free diet: a condition similar to that present in irritable bowel syndrome patients? 94
Hepatic steatosis in obese patients: clinical aspects and prognostic significance. 94
Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, costipation-variant: results of a multicenter trial 93
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 93
Genetic polymorphisms of PPAR-alpha: allele frequency in gallstone patients. 93
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. 93
Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature 93
Italian consensus conference for colonic diverticulosis and diverticular disease 92
Percutaneous liver biopsy in the clinical management of hepatocellular carcinoma:back to the future 92
HIGH FREE AND GLYCOCONJUGATED AND LOW TAUROCONJUGATED BA LEVELS IN SERUM ARE THE MIRROR OF INTESTINAL EVENTS AND HEPATIC UPTAKE 91
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness. 91
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure 89
Serum TUDCA/UDCA concentration profiles after TUDCA oral load: A new test for intestinal transit time and bacteria overgrowth evaluation 88
The foetal-maternal circulation of bile acids and bilirubin: effects of cholestasis and UDCA administration. 88
Terapia dell'encefalopatia epatica 86
Totale 11.891
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.999
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.296 0 0 0 0 0 393 457 453 449 213 120 211
2020/20211.821 375 118 58 70 15 77 25 96 177 81 83 646
2021/20222.583 241 119 139 156 211 143 60 119 88 149 771 387
2022/20232.529 286 355 158 324 162 195 52 134 454 61 176 172
2023/2024640 38 114 38 72 43 150 23 51 35 31 22 23
2024/20251.507 94 450 223 158 481 101 0 0 0 0 0 0
Totale 14.072